Stryker (SYK) Non-Current Debt (2009 - 2026)
Stryker's (SYK) quarterly Non-Current Debt came in at $14.2 billion in Q2 2026, down 4.3% year-over-year from $14.8 billion in Q2 2025, and little changed quarter-over-quarter from $14.2 billion in Q1 2026.
Analysis
Stryker (SYK) Non-Current Debt (2009 - 2026) Analysis & Trends
Stryker (SYK) has reported Non-Current Debt for 18 consecutive years, with $14.2 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Non-Current Debt fell 4.3% year-over-year to $14.2 billion in Q2 2026; TTM through Jun 2026 was $14.2 billion, a 4.3% decrease from a year earlier, with the FY2025 full-year figure at $14.9 billion, up 21.91% from the prior year.
- Non-Current Debt was $14.2 billion for Q2 2026 at Stryker, roughly flat from $14.2 billion in the prior quarter.
- Over five years, Non-Current Debt peaked at $14.9 billion in Q4 2025 and troughed at $10.1 billion in Q2 2024.
- A 5-year average of $12.8 billion and a median of $13.0 billion in 2022 frame the typical range for Non-Current Debt.
- Across the five-year window, Non-Current Debt slipped 18.58% in 2023 and soared 46.43% in 2025, its largest moves.
- Over 5 years, Non-Current Debt stood at $11.9 billion in 2022, then dropped by 8.06% to $10.9 billion in 2023, then grew by 11.81% to $12.2 billion in 2024, then rose by 21.91% to $14.9 billion in 2025, then declined by 4.49% to $14.2 billion in 2026.
- The last three Non-Current Debt figures came in at $14.2 billion (Q2 2026), $14.2 billion (Q1 2026), and $14.9 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 29.60 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 25.62 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 14.19 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 10.92 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 598.70 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -1.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 1.65 Bn |
| 10 | Zimmer Biomet Holdings | 18.20 Bn | 17.79 Bn | 1.54 Bn | 6.28 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.19 Bn |
| Mar 31, 2026 | 14.22 Bn |
| Dec 31, 2025 | 14.86 Bn |
| Sep 30, 2025 | 14.85 Bn |
| Jun 30, 2025 | 14.83 Bn |
| Mar 31, 2025 | 14.38 Bn |
| Dec 31, 2024 | 12.19 Bn |
| Sep 30, 2024 | 13.33 Bn |
| Jun 30, 2024 | 10.13 Bn |
| Mar 31, 2024 | 10.81 Bn |
| Dec 31, 2023 | 10.90 Bn |
| Sep 30, 2023 | 10.38 Bn |
| Jun 30, 2023 | 11.15 Bn |
| Mar 31, 2023 | 11.86 Bn |
| Dec 31, 2022 | 11.86 Bn |
| Sep 30, 2022 | 12.75 Bn |
| Jun 30, 2022 | 13.37 Bn |
| Mar 31, 2022 | 13.89 Bn |
| Dec 31, 2021 | 12.47 Bn |
| Sep 30, 2021 | 12.63 Bn |